Cipla Ltd
NSE:CIPLA

Watchlist Manager
Cipla Ltd Logo
Cipla Ltd
NSE:CIPLA
Watchlist
Price: 1 486.5 INR 1.75% Market Closed
Market Cap: 1.2T INR
Have any thoughts about
Cipla Ltd?
Write Note

Intrinsic Value

The intrinsic value of one CIPLA stock under the Base Case scenario is 1 173.46 INR. Compared to the current market price of 1 486.5 INR, Cipla Ltd is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CIPLA Intrinsic Value
1 173.46 INR
Overvaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cipla Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CIPLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CIPLA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Cipla Ltd

Provide an overview of the primary business activities
of Cipla Ltd.

What unique competitive advantages
does Cipla Ltd hold over its rivals?

What risks and challenges
does Cipla Ltd face in the near future?

Has there been any significant insider trading activity
in Cipla Ltd recently?

Summarize the latest earnings call
of Cipla Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cipla Ltd.

Provide P/S
for Cipla Ltd.

Provide P/E
for Cipla Ltd.

Provide P/OCF
for Cipla Ltd.

Provide P/FCFE
for Cipla Ltd.

Provide P/B
for Cipla Ltd.

Provide EV/S
for Cipla Ltd.

Provide EV/GP
for Cipla Ltd.

Provide EV/EBITDA
for Cipla Ltd.

Provide EV/EBIT
for Cipla Ltd.

Provide EV/OCF
for Cipla Ltd.

Provide EV/FCFF
for Cipla Ltd.

Provide EV/IC
for Cipla Ltd.

Show me price targets
for Cipla Ltd made by professional analysts.

What are the Revenue projections
for Cipla Ltd?

How accurate were the past Revenue estimates
for Cipla Ltd?

What are the Net Income projections
for Cipla Ltd?

How accurate were the past Net Income estimates
for Cipla Ltd?

What are the EPS projections
for Cipla Ltd?

How accurate were the past EPS estimates
for Cipla Ltd?

What are the EBIT projections
for Cipla Ltd?

How accurate were the past EBIT estimates
for Cipla Ltd?

Compare the revenue forecasts
for Cipla Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cipla Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cipla Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cipla Ltd compared to its peers.

Compare the P/E ratios
of Cipla Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Cipla Ltd with its peers.

Analyze the financial leverage
of Cipla Ltd compared to its main competitors.

Show all profitability ratios
for Cipla Ltd.

Provide ROE
for Cipla Ltd.

Provide ROA
for Cipla Ltd.

Provide ROIC
for Cipla Ltd.

Provide ROCE
for Cipla Ltd.

Provide Gross Margin
for Cipla Ltd.

Provide Operating Margin
for Cipla Ltd.

Provide Net Margin
for Cipla Ltd.

Provide FCF Margin
for Cipla Ltd.

Show all solvency ratios
for Cipla Ltd.

Provide D/E Ratio
for Cipla Ltd.

Provide D/A Ratio
for Cipla Ltd.

Provide Interest Coverage Ratio
for Cipla Ltd.

Provide Altman Z-Score Ratio
for Cipla Ltd.

Provide Quick Ratio
for Cipla Ltd.

Provide Current Ratio
for Cipla Ltd.

Provide Cash Ratio
for Cipla Ltd.

What is the historical Revenue growth
over the last 5 years for Cipla Ltd?

What is the historical Net Income growth
over the last 5 years for Cipla Ltd?

What is the current Free Cash Flow
of Cipla Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cipla Ltd.

Business Breakdown

Cipla Ltd. stands as a prominent player in the global pharmaceutical landscape, rooted in its founding vision of accessible healthcare for all. Established in 1935 in India, the company has evolved from its initial focus on producing affordable medicines to becoming a leading provider of generic and specialty pharmaceuticals, over-the-counter products, and active pharmaceutical ingredients (APIs). With a strong commitment to innovation, Cipla allocates a significant portion of its resources to research and development, leading to a robust pipeline of patented and life-saving treatments, particularly in the fields of respiratory, HIV/AIDS, and oncology therapies. This focus on both global mar...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cipla Ltd

Current Assets 209.5B
Cash & Short-Term Investments 87.1B
Receivables 55.9B
Other Current Assets 66.5B
Non-Current Assets 137.1B
Long-Term Investments 12.2B
PP&E 62.2B
Intangibles 51.1B
Other Non-Current Assets 11.6B
Current Liabilities 54.5B
Accounts Payable 26.8B
Other Current Liabilities 27.8B
Non-Current Liabilities 8.4B
Long-Term Debt 2.2B
Other Non-Current Liabilities 6.2B
Efficiency

Earnings Waterfall
Cipla Ltd

Revenue
265.1B INR
Cost of Revenue
-87.5B INR
Gross Profit
177.7B INR
Operating Expenses
-121.4B INR
Operating Income
56.2B INR
Other Expenses
-11.5B INR
Net Income
44.8B INR

Free Cash Flow Analysis
Cipla Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 FY '25, Cipla reported record EBITDA margins at 26.7%, reflecting strong profitability amid a 9% revenue growth to INR 7,051 crores. The slower growth in their One India business was due to changes in the seasonal pattern, especially in acute therapies, with anti-infectives growing only 4.9%. However, chronic therapies like respiratory and cardiac grew by 9% and 11%, respectively. For FY '25, Cipla maintains an EBITDA margin guidance of 24.5% to 25.5%. Although they face temporary supply issues in the Lanreotide franchise, recovery is expected by Q4 FY '25. The company continues to invest in expansion and strategically develop key markets.

What is Earnings Call?
Fundamental Scores

CIPLA Profitability Score
Profitability Due Diligence

Cipla Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Operating Income
61/100
Profitability
Score

Cipla Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

CIPLA Solvency Score
Solvency Due Diligence

Cipla Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
99/100
Solvency
Score

Cipla Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CIPLA Price Targets Summary
Cipla Ltd

Wall Street analysts forecast CIPLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CIPLA is 1 658.23 INR with a low forecast of 1 216.04 INR and a high forecast of 2 058 INR.

Lowest
Price Target
1 216.04 INR
18% Downside
Average
Price Target
1 658.23 INR
12% Upside
Highest
Price Target
2 058 INR
38% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CIPLA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CIPLA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CIPLA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Cipla Ltd Logo
Cipla Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

1.2T INR

Dividend Yield

0.87%

Description

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 21,891 full-time employees. The Company’s segments include Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. Its product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The firm's geographical segments include India, the United States, South Africa and Rest of the World. The firm has its network of manufacturing, trading and other incidental operations in India and International markets. The firm has approximately 46 manufacturing sites.

Contact

MAHARASHTRA
Mumbai
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel,
+912224826000
www.cipla.com

IPO

1994-11-03

Employees

21 891

Officers

MD, Global CEO & Executive Director
Mr. Umang Vohra B.E., M.B.A.
President & Global Chief People Officer
Dr. Raju Sunil Mistry M.A., Ph.D.
President & Global Chief Scientific Officer
Mr. Pradeep Bhadauria
Global Chief Financial Officer
Mr. Ashish Adukia
Senior VP & Head of Corporate Finance
Mr. Dinesh Ramniranjan Jain
Chief Information Officer
Ms. Sneha Hiranandani B Com
Show More
Compliance Officer & Company Secretary
Mr. Rajendra Kumar Chopra
Senior Vice-President of Corporate Communications
Ms. Heena Kanal
Global Chief Medical Officer
Dr. Jaideep A. Gogtay M.D., Ph.D.
Head of Cipla Foundation
Mr. Anurag Mishra
Show Less

See Also

Discover More
What is the Intrinsic Value of one CIPLA stock?

The intrinsic value of one CIPLA stock under the Base Case scenario is 1 173.46 INR.

Is CIPLA stock undervalued or overvalued?

Compared to the current market price of 1 486.5 INR, Cipla Ltd is Overvalued by 21%.

Back to Top